GGrantIndex
Sort

53,477 grants matching addiction

Novel mechanisms for correcting opioid-induced synaptic abnormalities

$464,289
John A Wemmie · University Of Iowa · R01 · FY2021 · DA

Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability

$464,257
Elizabeth M Byrnes · Tufts University Boston · R01 · FY2023 · DA

Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability

$464,257
Elizabeth M Byrnes · Tufts University Boston · R01 · FY2021 · DA

Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability

$464,257
Elizabeth M Byrnes · Tufts University Boston · R01 · FY2024 · DA

Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability

$464,257
Elizabeth M Byrnes · Tufts University Boston · R01 · FY2022 · DA

Membrane Trafficking of Opioid and Adrenergic Receptors

$464,186
Mark E. Von Zastrow · University Of California, San Francisco · R01 · FY2022 · DA

Genes Contributing to Opioid Abuse in Humans

$464,175
Kari Stefansson · Decode Genetics, Inc. · R01 · FY2008 · DA

Changes in Addictive Behaviors After Brain Lesions

$464,162
Antoine Bechara · University Of Southern California · R01 · FY2008 · DA

Treatment-Induced Phenotypic Reprogramming in Prostate Cancer

$464,108
Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain

$464,079
Dong Wang · University Of Nebraska Medical Center · R01 · FY2024 · AR

Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction

$464,065
Subramaniam Ananthan · Southern Research Institute · R01 · FY2011 · DA

Metabolic Phenotyping System

$464,064
Scot R Kimball · Pennsylvania State Univ Hershey Med Ctr · S10 · FY2020 · OD

Training Program: Drugs of Abuse and Related Neuropeptides

$464,030
Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2010 · DA

Impacts of universal access to HIV/AIDS care among HIV+ injection drug users

$463,866
Evan Wood · University Of British Columbia · R01 · FY2007 · DA

Medications Development for Drug Abuse Disorders

$463,830
Johns Hopkins University · R01 · FY2004 · DA

Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement

$463,811
David Weinshenker · Emory University · R01 · FY2024 · DA

Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement

$463,811
David Weinshenker · Emory University · R01 · FY2023 · DA

Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement

$463,811
David Weinshenker · Emory University · R01 · FY2022 · DA

Frontostriatal Rhythms Underlying Reinforcement Learning.

$463,781
Jonathan D Wallis · University Of California Berkeley · R01 · FY2018 · MH

Pilot Projects Program Core

$463,780
Jonathan M. Samet · University Of Southern California · P50 · FY2017 · CA

Mechanisms of Nicotine Inhalation-Induced Cardiovascular Disease

$463,750
Jay Louis Zweier · Ohio State University · R01 · FY2017 · HL

Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement

$463,741
David Weinshenker · Emory University · R01 · FY2021 · DA

Ethanol Mechanisms in GABAAR Gene Targeted Mice

$463,697
Gregg E Homanics · University Of Pittsburgh At Pittsburgh · R37 · FY2015 · AA

Licit Abused Drugs

$463,603
Roland R Griffiths · Johns Hopkins University · R01 · FY2014 · DA

Membrane Trafficking of Opioid and Adrenergic Receptors

$463,600
Mark E. Von Zastrow · University Of California, San Francisco · R01 · FY2023 · DA